QQQ   354.84 (-0.02%)
AAPL   179.21 (-0.21%)
MSFT   333.68 (-0.67%)
META   271.12 (-0.10%)
GOOGL   127.31 (+1.03%)
AMZN   126.61 (+1.05%)
TSLA   221.31 (+1.70%)
NVDA   386.54 (-1.32%)
NIO   7.87 (+2.61%)
BABA   86.69 (+2.71%)
AMD   124.23 (+5.34%)
T   15.66 (+1.75%)
F   12.93 (+2.70%)
MU   67.54 (-0.34%)
CGC   0.74 (-5.13%)
GE   105.46 (+1.31%)
DIS   92.16 (+1.27%)
AMC   4.64 (+0.22%)
PFE   38.37 (-0.72%)
PYPL   65.02 (+0.79%)
NFLX   399.29 (-1.05%)
QQQ   354.84 (-0.02%)
AAPL   179.21 (-0.21%)
MSFT   333.68 (-0.67%)
META   271.12 (-0.10%)
GOOGL   127.31 (+1.03%)
AMZN   126.61 (+1.05%)
TSLA   221.31 (+1.70%)
NVDA   386.54 (-1.32%)
NIO   7.87 (+2.61%)
BABA   86.69 (+2.71%)
AMD   124.23 (+5.34%)
T   15.66 (+1.75%)
F   12.93 (+2.70%)
MU   67.54 (-0.34%)
CGC   0.74 (-5.13%)
GE   105.46 (+1.31%)
DIS   92.16 (+1.27%)
AMC   4.64 (+0.22%)
PFE   38.37 (-0.72%)
PYPL   65.02 (+0.79%)
NFLX   399.29 (-1.05%)
QQQ   354.84 (-0.02%)
AAPL   179.21 (-0.21%)
MSFT   333.68 (-0.67%)
META   271.12 (-0.10%)
GOOGL   127.31 (+1.03%)
AMZN   126.61 (+1.05%)
TSLA   221.31 (+1.70%)
NVDA   386.54 (-1.32%)
NIO   7.87 (+2.61%)
BABA   86.69 (+2.71%)
AMD   124.23 (+5.34%)
T   15.66 (+1.75%)
F   12.93 (+2.70%)
MU   67.54 (-0.34%)
CGC   0.74 (-5.13%)
GE   105.46 (+1.31%)
DIS   92.16 (+1.27%)
AMC   4.64 (+0.22%)
PFE   38.37 (-0.72%)
PYPL   65.02 (+0.79%)
NFLX   399.29 (-1.05%)
QQQ   354.84 (-0.02%)
AAPL   179.21 (-0.21%)
MSFT   333.68 (-0.67%)
META   271.12 (-0.10%)
GOOGL   127.31 (+1.03%)
AMZN   126.61 (+1.05%)
TSLA   221.31 (+1.70%)
NVDA   386.54 (-1.32%)
NIO   7.87 (+2.61%)
BABA   86.69 (+2.71%)
AMD   124.23 (+5.34%)
T   15.66 (+1.75%)
F   12.93 (+2.70%)
MU   67.54 (-0.34%)
CGC   0.74 (-5.13%)
GE   105.46 (+1.31%)
DIS   92.16 (+1.27%)
AMC   4.64 (+0.22%)
PFE   38.37 (-0.72%)
PYPL   65.02 (+0.79%)
NFLX   399.29 (-1.05%)
OTCMKTS:CDMGF

Icade (CDMGF) Stock Forecast, Price & News

$45.17
0.00 (0.00%)
(As of 06/6/2023 ET)
Compare
Today's Range
$45.17
▼
$45.17
50-Day Range
$44.49
▼
$47.14
52-Week Range
$44.49
▼
$52.21
Volume
N/A
Average Volume
457 shs
Market Capitalization
N/A
P/E Ratio
36.97
Dividend Yield
8.13%
Price Target
$55.75
ProfileAnalyst RatingsChartCompetitorsHeadlinesShort Interest

Icade MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
23.4% Upside
$55.75 Price Target
Short Interest
Bearish
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.27 out of 5 stars

See Top Rated MarketRank™ Stocks Here

CDMGF stock logo

About Icade (OTCMKTS:CDMGF) Stock

As an investor and a developer, Icade is an integrated real estate player that designs innovative real estate products and services adapted to new urban lifestyles and habits. By placing corporate social responsibility and innovation at the core of its strategy, Icade is closely involved with stakeholders and users in the citieslocal authorities and communities, companies and employees, institutions and associations. As an office and healthcare property investor (portfolio value of 11.6bn as of 06/30/2020 on a proportionate consolidation basis) and as a property developer (2019 economic revenues of nearly 1bn), Icade has been able to reinvent the real estate business and foster the emergence of tomorrow's greener, smarter and more responsible cities. Icade is a significant player in the Greater Paris area and major French cities. Icade is listed on Euronext Paris as a French Listed Real Estate Investment Company (société d'investissement immobilier cotée, SIIC). Its leading shareholder is the Caisse des dépôts Group.

Receive CDMGF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Icade and its competitors with MarketBeat's FREE daily newsletter.

CDMGF Stock News Headlines

May 14, 2023 | americanbankingnews.com
Brokerages Set Icade (OTCMKTS:CDMGF) PT at $55.75
May 3, 2023 | americanbankingnews.com
Icade (OTCMKTS:CDMGF) Short Interest Update
June 6, 2023 | Behind the Markets (Ad)
BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
April 21, 2023 | americanbankingnews.com
Icade (OTCMKTS:CDMGF) Given Average Rating of "Hold" by Brokerages
April 19, 2023 | americanbankingnews.com
Analysts Set Icade (OTCMKTS:CDMGF) PT at $55.75
April 3, 2023 | americanbankingnews.com
Short Interest in Icade (OTCMKTS:CDMGF) Expands By 10.4%
March 27, 2023 | americanbankingnews.com
Icade (OTCMKTS:CDMGF) Receives Consensus Recommendation of "Hold" from Analysts
March 22, 2023 | americanbankingnews.com
Icade (OTCMKTS:CDMGF) Rating Increased to Overweight at Morgan Stanley
June 6, 2023 | Behind the Markets (Ad)
BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
November 28, 2022 | marketwatch.com
Icad Rises on Google Health Development Deal
November 10, 2022 | msn.com
Icad (ICAD) Reports Q3 Loss, Lags Revenue Estimates
September 23, 2022 | finance.yahoo.com
Icade (ICAD.PA)
August 19, 2022 | nasdaq.com
After Plunging 29.6% in 4 Weeks, Here's Why the Trend Might Reverse for Icad (ICAD)
May 15, 2022 | seekingalpha.com
Icade: Align Yourself With French Governmental Real Estate
February 28, 2022 | sfgate.com
Icad: Q4 Earnings Snapshot
February 21, 2022 | msn.com
Analysts Estimate Icad (ICAD) to Report a Decline in Earnings: What to Look Out for
November 9, 2021 | entrepreneur.com
Icad (ICAD) Reports Q3 Loss, Misses Revenue Estimates
November 9, 2021 | chron.com
Icad: Q3 Earnings Snapshot
November 2, 2021 | msn.com
Earnings Preview: Icad (ICAD) Q3 Earnings Expected to Decline
September 16, 2021 | benzinga.com
Director Of Icad Makes $217.70 Thousand Sale
August 5, 2021 | nasdaq.com
Icad (ICAD) Reports Q2 Loss, Lags Revenue Estimates
July 29, 2021 | finance.yahoo.com
Icad (ICAD) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
April 28, 2021 | apnews.com
Icad: Q1 Earnings Snapshot
April 28, 2021 | nasdaq.com
Icad (ICAD) Reports Q1 Loss, Tops Revenue Estimates
See More Headlines

CDMGF Price History

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
REIT - Diversified
Sub-Industry
N/A
Sector
Real Estate
Current Symbol
OTCMKTS:CDMGF
CUSIP
N/A
CIK
N/A
Web
www.icade.fr
Phone
33 1 41 57 70 00
Fax
N/A
Employees
1,178
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$55.75
High Stock Price Forecast
$68.50
Low Stock Price Forecast
$41.00
Forecasted Upside/Downside
+23.4%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
9 Analysts

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
36.97
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. Olivier Wigniolle (Age 60)
    MD & CEO
    Comp: $508.75k
  • Ms. Victoire Aubry (Age 57)
    Head of Fin., IT & Work Environment
  • Ms. Sophie Duval
    Head of Consolidation & Accounting
  • Jean d'Aillières
    Head of Investor Relations
  • Ms. Anne-Sophie Lanaute
    Head of Financial Communication & Investor Relations
  • Mr. Jérôme Lucchini (Age 56)
    Gen. Sec. and Head of Governance, Legal Insurance & Department
  • Mr. Laurent Poinsard (Age 57)
    Head of Audit, Risk, Compliance & Internal Control
  • Ms. Marianne de Battisti (Age 67)
    Head of Institutional Relations & Group Communication
  • Mr. Marc le Blanc (Age 46)
    Head of HR
  • Ms. Emmanuelle Baboulin (Age 57)
    Head of the Commercial Property Investment Division

Key Competitors

View All Competitors













CDMGF Stock - Frequently Asked Questions

Should I buy or sell Icade stock right now?

9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Icade in the last year. There are currently 3 sell ratings, 3 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" CDMGF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CDMGF, but not buy additional shares or sell existing shares.
View CDMGF analyst ratings or view top-rated stocks.

What is Icade's stock price forecast for 2023?

9 equities research analysts have issued 1 year target prices for Icade's shares. Their CDMGF share price forecasts range from $41.00 to $68.50. On average, they expect the company's stock price to reach $55.75 in the next year. This suggests a possible upside of 23.4% from the stock's current price.
View analysts price targets for CDMGF or view top-rated stocks among Wall Street analysts.

How have CDMGF shares performed in 2023?

Icade's stock was trading at $42.4150 at the start of the year. Since then, CDMGF shares have increased by 6.5% and is now trading at $45.1650.
View the best growth stocks for 2023 here.

Is Icade a good dividend stock?

Icade (OTCMKTS:CDMGF) pays an annual dividend of $3.67 per share and currently has a dividend yield of 6.28%. CDMGF has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 300.37%. Payout ratios above 75% are not desirable because they may not be sustainable.

What is Icade's stock symbol?

Icade trades on the OTCMKTS under the ticker symbol "CDMGF."

How do I buy shares of Icade?

Shares of CDMGF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Icade's stock price today?

One share of CDMGF stock can currently be purchased for approximately $45.17.

How many employees does Icade have?

The company employs 1,178 workers across the globe.

How can I contact Icade?

Icade's mailing address is Millénaire 1, Paris, Ile-de-France 75019. The official website for the company is www.icade.fr. The company can be reached via phone at 33 1 41 57 70 00.

This page (OTCMKTS:CDMGF) was last updated on 6/6/2023 by MarketBeat.com Staff

My Account -